Cell Viability Assays Market Size Is Expected To Reach USD 3.01 Billion By 2030
![Image](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjWb-Zr5Xcgj5TkUxlK9IOGqwUB1hX2LWwy1Tb-TABi3OYWIV4Q6TA4PIuae3CydlSMUN88agj_ayg5i-5dHVviaEs-mdke0mcx-ANZVENkMrhbfd8pGDL-v7b3osflX_iZMNq85zw4IQQkQwy1gmFnidUzpQj4xHkpkmMhEmi59z6r4MhvvjYKfpf2lSy-/s320/Cell%20Viability%20Assays%20Market.png)
San Francisco, 11 July 2023: The Report Cell Viability Assays Market Size, Share & Trends Analysis Report By Product (Consumables, Instruments), By Application (Drug Discovery & Development, Stem Cell Research), By End-user, By Region, And Segment Forecasts, 2023 - 2030 The global cell viability assays market size is expected to reach USD 3.01 billion by 2030, according to a new report by Grand View Research, Inc., expanding at a CAGR of 9.94% from 2023 to 2030. The rising prevalence of chronic and infectious diseases and the increasing focus on cell-based therapeutics are expanding the growth prospects of the market. In addition, growing funding for cell-based research and increasing use of automated instruments are the key factors driving the market for cell viability assays (CVAs). Increasing funding and investments for cell-based research are expanding growth prospects for cell viability assays. For instance, in May 2022, the California Institute for Regenerative Medic